Neoadjuvant Chemotherapy in Biliary Tract Cancer

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
16:02

ecancer

Selecting Patients Wisely for Neoadjuvant Therapy in Pancreatic and Hepatobiliary Cancers

FEATURING Shailesh Shrikhande
  • 37 views
  • November 10, 2024
12:38

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Refining Treatment in Advanced Hepatobiliary Cancers"

FEATURING Laura Goff
  • 129 views
  • June 12, 2024
  • 1
09:13

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary Cancer Including CheckMate 9DW and ABC-07 Trials"

FEATURING Nataliya Uboha, Kristen Spencer, Michael Cecchini
  • 243 views
  • June 10, 2024
  • 1
28:25

Integrity CE

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentation and Panel Discussion

FEATURING Valerie Lee, Eric Christenson, Nikhil Bhagat, Emily Winslow
  • 271 views
  • March 27, 2024
  • 3
22:33

Integrity CE

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel Discussion

FEATURING Valerie Lee, Rachit Kumar, Nikhil Bhagat, Emily Winslow
  • 416 views
  • March 27, 2024
  • 6
21:46

Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Past, Present & Future Clinical Management of Advanced Biliary Tract Cancers"

FEATURING Masafumi Ikeda
  • 306 views
  • January 17, 2024
16:40

Moffitt Cancer Center

Year in Review: Hepatobiliary Cancers

FEATURING Richard Kim, Tiago Biachi
  • 611 views
  • December 22, 2023
  • 4
14:54

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highlights"

FEATURING Lorenza Rimassa
  • 441 views
  • October 28, 2023
  • 4
03:50

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Post Hoc Analysis of the ABC-01, -02 and -03 Clinical Trials - Advanced Extrahepatic Cholangiocarcinoma"

FEATURING Angela Lamarca
  • 176 views
  • October 26, 2023
  • 1
14:37

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Randomized, Double-Blind, Placebo-Controlled D-TORCH Study - Topical Diclofenac in Prevention of Hand-Foot Syndrome in Patients Receiving Capecitabine"

FEATURING Atul Batra
  • 180 views
  • August 7, 2023
  • 1
13:12

Penn Medicine Abramson Cancer Center

Penn Medicine Updates in Oncology 2023: CRC, Pancreatic Cancer, and BTC

FEATURING Ryan Massa
  • 190 views
  • July 11, 2023
  • 2
09:14

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results From the Pivotal Phase 2b HERIZON-BTC-01 Study - Zanidatamab in Previously-Treated HER2‑Amplified Biliary Tract Cancer"

FEATURING Shubham Pant
  • 95 views
  • June 21, 2023
  • 1
11:09

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 2 Basket Study of Tucatinib & Trastuzumab for Previously Treated HER2+ Metastatic Biliary Tract Cancer (SGNTUC-019)"

FEATURING Yoshiaki Nakamura
  • 120 views
  • June 15, 2023
05:46

Penn Medicine Abramson Cancer Center

Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials

FEATURING Thomas Karasic
  • 306 views
  • May 25, 2023
  • 3
09:05

AACR 2023 Conference Coverage

AACR 2023 on KEYNOTE-966 Phase 3 Study: Pembro in Combination With Gemcitabine & Cisplatin for Advanced Biliary Tract Cancer

FEATURING Katie Kelley
  • 353 views
  • May 10, 2023
  • 4
06:44

Total Health

2023 Case-Based Clinical Updates in Gastroesophageal and Biliary Tract Cancers

FEATURING Edith Mitchell
  • 75 views
  • April 3, 2023
12:39

Total Health

Updates in the Systemic Therapy for Biliary Tract Cancers

FEATURING Thatcher Heumann
  • 164 views
  • March 8, 2023
  • 1
09:06

2023 Johns Hopkins Updates in Gastrointestinal Cancers

Great Debate: Neoadjuvant vs. Adjuvant Therapy for High-Risk BTC - Pro Neoadjuvant

FEATURING Thomas Karasic
  • 371 views
  • March 7, 2023
  • 1
23:37

2023 Johns Hopkins Updates in Gastrointestinal Cancers

Medical Oncology Updates in BTC

FEATURING Marina Baretti
  • 246 views
  • March 7, 2023
  • 1
30:00

2023 Johns Hopkins Updates in Gastrointestinal Cancers

Managing Treatment-Related Side Effects in GI Cancers: Chemo, Targeted Therapy, and IO

FEATURING Paige Griffith
  • 254 views
  • March 7, 2023
  • 1
05:32

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Phase 3 Randomized SWOG 1815 Trial: Gemcitabine, Cisplatin, & nab-Paclitaxel vs. Gemcitabine & Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

FEATURING Rachna Shroff
  • 257 views
  • February 1, 2023
  • 4
04:41

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Characterization of Long-Term Survivors in the TOPAZ-1 Study: Durvalumab or Placebo + Gemcitabine & Cisplatin in Advanced Biliary Tract Cancer

FEATURING Mohamed Bouattour
  • 313 views
  • January 28, 2023
  • 2
27:37

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

FEATURING Nataliya Uboha, Anita Turk, Kristen Spencer, Michael Cecchini
  • 4,121 views
  • January 26, 2023
  • 19
10:41

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Phase 2, Randomized, Double-Blind, Placebo-Controlled IMbrave151 Study: Bev + Atezo & Gem/Cis in Advanced Biliary Tract Cancer

FEATURING Anthony El-Khoueiry
  • 206 views
  • January 25, 2023
  • 1
15:42

Richard Kim

Treatment Algorithm Series: Management of Advanced Cholangiocarcinoma

FEATURING Amit Mahipal
  • 351 views
  • November 23, 2022
  • 5

Neoadjuvant Chemotherapy in Biliary Tract Cancer

No subtopics